focus -WSS

focus

author：knowledge 2025-09-27 10:06:01 - browse：133

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： How Medicaid coverage policies for immigrants impact new moms

Wikipedia

WSS

In early work, researchers turn to CRISPR to treat Alzheimer's

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Pfizer's Covid pill remains 89% effective in final analysis, company says

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

knowledge

Supreme Court strikes down use of affirmative action

How Medicaid coverage policies for immigrants impact new moms

Hollywood unions extend contract negotiations for actors

These geoengineering technologies could help combat the climate crisis, scientists say

23andMe had bad news about my health. I wish a person had delivered it

At Orexo, a ‘turning point’ for everything but digital health

Hollywood unions extend contract negotiations for actors

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Duchenne breakthrough therapy leaves behind pioneering families

4th of July breaks record for highest global temperature ever measured

hotspot

Inside the fall of star MIT scientist David Sabatini

Australia's humpback populations rebound raising hopes of marine scientists

Doctor appointment wait times are getting worse

These geoengineering technologies could help combat the climate crisis, scientists say

Australia's humpback populations rebound raising hopes of marine scientists

Meta looks to target Twitter with a rival app called Threads

hotspot

hotspot

Wikipedia

hotspot